User menu

Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†

Bibliographic reference Gourgou-Bourgade, S ; Cameron, D ; Poortmans, P ; Asselain, B ; Azria, D ; et. al. Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†. In: Annals of Oncology, Vol. 26, no.5, p. 873-879 (2015)
Permanent URL http://hdl.handle.net/2078.1/175639